Critical Role of Computer Simulations in Drug Discovery and Development
The last couple of decades has witnessed that an amalgamation of multidisciplinary branches of science come together in the form of 'Bioinformatics' and made a substantial impact on the drug designing process. The applicability of Bioinformatics approaches has been able to lower down the overall cost and time of drug discovery and development. The Computer Aided Drug Designing System (CADDS) using extensive applicability of Bioinformatics has been recognized as one step ahead to carry out the primary high throughput virtual screening as an economically viable solution to the problem. The present article discusses the applicability of various Bioinformatics tools for virtual screening and molecular dynamics of selected molecules/ active ingredients derived from herbs, semi-synthetic and synthetic compounds, to predict their possible therapeutic interventions in diabetes induced neuropathy and neurodegenerative disorders. The article ends by summarizing the application of the virtual screening, lead optimization and predictions of bioavailability and bioactivity in the experimental drug development research..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
---|---|
Enthalten in: |
Current topics in medicinal chemistry - 17(2017), 21, Seite 2422-2432 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Prachi Srivastava [VerfasserIn] |
---|
Links: |
---|
BKL: |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
OLC1996434020 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1996434020 | ||
003 | DE-627 | ||
005 | 20230512170911.0 | ||
007 | tu | ||
008 | 170901s2017 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a PQ20170901 |
035 | |a (DE-627)OLC1996434020 | ||
035 | |a (DE-599)GBVOLC1996434020 | ||
035 | |a (PRQ)benthamscience_primary_http_www_eurekaselect_com_openurl_content_php_genre_article_issn_1568_0266_volume_17_issue_21_spage_24220 | ||
035 | |a (KEY)0446467220170000017002102422criticalroleofcomputersimulationsindrugdiscoveryan | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 540 |q DE-600 |
084 | |a PHARM |2 fid | ||
084 | |a 44.40 |2 bkl | ||
100 | 0 | |a Prachi Srivastava |e verfasserin |4 aut | |
245 | 1 | 0 | |a Critical Role of Computer Simulations in Drug Discovery and Development |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
520 | |a The last couple of decades has witnessed that an amalgamation of multidisciplinary branches of science come together in the form of 'Bioinformatics' and made a substantial impact on the drug designing process. The applicability of Bioinformatics approaches has been able to lower down the overall cost and time of drug discovery and development. The Computer Aided Drug Designing System (CADDS) using extensive applicability of Bioinformatics has been recognized as one step ahead to carry out the primary high throughput virtual screening as an economically viable solution to the problem. The present article discusses the applicability of various Bioinformatics tools for virtual screening and molecular dynamics of selected molecules/ active ingredients derived from herbs, semi-synthetic and synthetic compounds, to predict their possible therapeutic interventions in diabetes induced neuropathy and neurodegenerative disorders. The article ends by summarizing the application of the virtual screening, lead optimization and predictions of bioavailability and bioactivity in the experimental drug development research. | ||
700 | 0 | |a Anshul Tiwari |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Current topics in medicinal chemistry |d Hilversum [u.a.] : Bentham Science Publ., 2001 |g 17(2017), 21, Seite 2422-2432 |w (DE-627)338770283 |w (DE-600)2064823-6 |w (DE-576)435515160 |x 1568-0266 |7 nnns |
773 | 1 | 8 | |g volume:17 |g year:2017 |g number:21 |g pages:2422-2432 |
856 | 4 | 2 | |u http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1568-0266&volume=17&issue=21&spage=2422 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a SSG-OPC-PHA | ||
912 | |a GBV_ILN_4219 | ||
936 | b | k | |a 44.40 |q AVZ |
951 | |a AR | ||
952 | |d 17 |j 2017 |e 21 |h 2422-2432 |